ES
COEPW

Equitec Specialists’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Equitec Specialists’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-34,180
Closed -$15K – 20
2021
Q1 		$15K Buy
34,180
+24,280
+245% +$22.8K ﹤0.01% 188
2020
Q4 		$14K Buy
+9,900
New +$9.13K ﹤0.01% 202

Other funds holding COEPW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
ICM
Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Equitec Specialists's COEPW Position: Q2 2021 in Review

Equitec Specialists sold out of Coeptis Therapeutics Warrants (COEPW) in Q2 2021, closing a stake of 34,180 shares — an estimated $15K sold.

Equitec Specialists first reported a position in COEPW in Q4 2020 and held it in 2 quarters. The position peaked at $15K in Q1 2021. 21 funds tracked by Wall St. Rank hold COEPW as of Q2 2021.

  • Equitec Specialists reported no remaining Coeptis Therapeutics Warrants position as of Q2 2021 after selling out during the quarter.
  • Equitec Specialists sold 34,180 Coeptis Therapeutics Warrants shares in Q2 2021, an estimated $15K.
  • Equitec Specialists first reported a position in Coeptis Therapeutics Warrants in Q4 2020 and held it in 2 quarters.
  • Equitec Specialists's Coeptis Therapeutics Warrants position peaked at $15K in Q1 2021.
  • 21 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q2 2021.

Based on Equitec Specialists's 13F filing for Q2 2021, filed 20 Jul 2021.